Increased NHE1 protein promotes glioma survival and we expected that blocking NHE1 function with NHE inhibitor HOE642 would sensitize glioma cells to TMZ-induced cytotoxicity. This evidence concerns the gene SLC9C1 and central nervous system cancer.